• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗癌药物喜树碱一些新类似物的理论研究

A theoretical study of some new analogues of the anti-cancer drug camptothecin.

作者信息

Jena Nihar R, Mishra Phool C

机构信息

Department of Physics, Banaras Hindu University, Varanasi, 221005, India.

出版信息

J Mol Model. 2007 Jan;13(1):267-74. doi: 10.1007/s00894-006-0157-4. Epub 2006 Oct 6.

DOI:10.1007/s00894-006-0157-4
PMID:17024403
Abstract

The enzyme topoisomerase I (topo I), which is essential for cell replication, transiently causes a DNA single strand break and makes a complex with it. The anti-cancer agent camptothecin (CPT) binds to the topo I-DNA complex and stabilizes it, preventing resealing of the broken DNA strand and cell growth. Considering the structural factors of CPT that are believed to be involved in stabilizing the topo I-DNA complex via hydrogen bonding and stacking interactions, designs of two new analogues of CPT (topo I inhibitors) have been suggested. The molecular geometries of CPT, two of its analogues and certain other related molecules included in the study were fully optimized in both gas phase and aqueous media at the B3LYP/6-311++G(d,p) level of density functional theory. Solvation effects of aqueous media were treated using the polarizable continuum model (PCM). Net CHelpG charges and surface molecular electrostatic potentials (MEP) near the atomic sites of the molecules were studied. Structural analogy and surface MEP values suggests that the two new CPT analogues studied here would be potent topoisomerase I inhibitors.

摘要

拓扑异构酶I(topo I)是细胞复制所必需的酶,它会暂时导致DNA单链断裂并与之形成复合物。抗癌药物喜树碱(CPT)与topo I-DNA复合物结合并使其稳定,从而阻止断裂的DNA链重新封闭以及细胞生长。考虑到据信通过氢键和堆积相互作用参与稳定topo I-DNA复合物的CPT的结构因素,已提出了两种新的CPT类似物(topo I抑制剂)的设计方案。在密度泛函理论的B3LYP/6-311++G(d,p)水平上,对CPT及其两种类似物以及该研究中包含的某些其他相关分子的分子几何结构在气相和水相中都进行了完全优化。使用极化连续介质模型(PCM)处理水相介质的溶剂化效应。研究了分子原子位点附近的净CHelpG电荷和表面分子静电势(MEP)。结构类比和表面MEP值表明,此处研究的两种新的CPT类似物将是有效的拓扑异构酶I抑制剂。

相似文献

1
A theoretical study of some new analogues of the anti-cancer drug camptothecin.抗癌药物喜树碱一些新类似物的理论研究
J Mol Model. 2007 Jan;13(1):267-74. doi: 10.1007/s00894-006-0157-4. Epub 2006 Oct 6.
2
Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.喜树碱与DNA拓扑异构酶I三元可裂解复合物的分子模拟研究
J Med Chem. 1998 Jun 18;41(13):2216-26. doi: 10.1021/jm9605445.
3
Action models for the antitumor drug camptothecin: formation of alkali-labile complex with DNA and inhibition of human DNA topoisomerase I.抗肿瘤药物喜树碱的作用模型:与DNA形成碱不稳定复合物并抑制人DNA拓扑异构酶I
J Biomol Struct Dyn. 2002 Dec;20(3):447-54. doi: 10.1080/07391102.2002.10506863.
4
Recent advances in topoisomerase I-targeting agents, camptothecin analogues.靶向拓扑异构酶I的药物喜树碱类似物的最新进展。
Mini Rev Med Chem. 2002 Dec;2(6):611-9. doi: 10.2174/1389557023405530.
5
Structure-based analysis of the effects of camptothecin on the activities of human topoisomerase I.基于结构的喜树碱对人拓扑异构酶I活性影响的分析
Ann N Y Acad Sci. 2000;922:56-64. doi: 10.1111/j.1749-6632.2000.tb07025.x.
6
An ab initio quantum mechanics calculation that correlates with ligand orientation and DNA cleavage site selectivity in camptothecin-DNA-topoisomerase I ternary cleavage complexes.一种与喜树碱-DNA-拓扑异构酶I三元切割复合物中的配体取向和DNA切割位点选择性相关的从头算量子力学计算。
J Am Chem Soc. 2005 Jul 20;127(28):9960-1. doi: 10.1021/ja042485n.
7
A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin.人拓扑异构酶I、DNA和喜树碱之间形成的三元可裂解复合物的结构模型。
Biochemistry. 2001 Aug 21;40(33):9792-8. doi: 10.1021/bi010913l.
8
Effect of E-ring modifications in camptothecin on topoisomerase I inhibition: a quantum mechanics treatment.喜树碱中E环修饰对拓扑异构酶I抑制作用的影响:量子力学研究
J Org Chem. 2005 Nov 11;70(23):9584-7. doi: 10.1021/jo0513360.
9
The current status of camptothecin analogues as antitumor agents.喜树碱类似物作为抗肿瘤药物的现状。
J Natl Cancer Inst. 1993 Feb 17;85(4):271-91. doi: 10.1093/jnci/85.4.271.
10
Camptothecin and its analogues: a review on their chemotherapeutic potential.喜树碱及其类似物:关于其化疗潜力的综述
Nat Prod Res. 2005 Jun;19(4):393-412. doi: 10.1080/14786410412331299005.

引用本文的文献

1
Theoretical Study on the Aggregation and Adsorption Behaviors of Anticancer Drug Molecules on Graphene/Graphene Oxide Surface.抗癌药物分子在石墨烯/氧化石墨烯表面上的聚集和吸附行为的理论研究。
Molecules. 2022 Oct 10;27(19):6742. doi: 10.3390/molecules27196742.
2
Ab initio study on the noncovalent adsorption of camptothecin anticancer drug onto graphene, defect modified graphene and graphene oxide.从头算研究喜树碱抗癌药物非共价吸附于石墨烯、缺陷修饰石墨烯和氧化石墨烯。
J Comput Aided Mol Des. 2013 Sep;27(9):807-21. doi: 10.1007/s10822-013-9681-3. Epub 2013 Oct 17.
3
Theoretical study on the molecular and electronic properties of some substances used for diabetes mellitus treatment.

本文引用的文献

1
Mechanisms of formation of 8-oxoguanine due to reactions of one and two OH* radicals and the H2O2 molecule with guanine: A quantum computational study.通过一个和两个OH*自由基以及H2O2分子与鸟嘌呤反应形成8-氧代鸟嘌呤的机制:量子计算研究
J Phys Chem B. 2005 Jul 28;109(29):14205-18. doi: 10.1021/jp050646j.
2
New hints on the Ph-driven tautomeric equilibria of the topotecan anticancer drug in aqueous solutions from an integrated spectroscopic and quantum-mechanical approach.基于光谱学与量子力学相结合的方法对拓扑替康抗癌药物在水溶液中由pH驱动的互变异构平衡的新线索
J Am Chem Soc. 2005 Nov 9;127(44):15429-36. doi: 10.1021/ja052637u.
3
一些用于治疗糖尿病物质的分子和电子性质的理论研究。
J Mol Model. 2010 Apr;16(4):799-804. doi: 10.1007/s00894-009-0627-6. Epub 2009 Dec 12.
4
Quinoline alkaloids as intercalative topoisomerase inhibitors.喹啉生物碱作为嵌入型拓扑异构酶抑制剂。
J Mol Model. 2009 Dec;15(12):1417-26. doi: 10.1007/s00894-009-0501-6. Epub 2009 May 8.
Dynamic behavior of DNA base pairs containing 8-oxoguanine.
含8-氧代鸟嘌呤的DNA碱基对的动态行为。
J Am Chem Soc. 2005 Oct 12;127(40):13906-18. doi: 10.1021/ja052542s.
4
Camptothecin: roles of the D and E rings in binding to the topoisomerase I-DNA covalent binary complex.
Curr Med Chem Anticancer Agents. 2005 Jul;5(4):353-62. doi: 10.2174/1568011054222373.
5
On the role of E-ring oxygen atoms in the binding of camptothecin to the topoisomerase I-DNA covalent binary complex.
Bioorg Med Chem. 2005 Feb 15;13(4):1381-6. doi: 10.1016/j.bmc.2004.11.011.
6
14-azacamptothecin: a potent water-soluble topoisomerase I poison.14-氮杂喜树碱:一种强效水溶性拓扑异构酶I毒药。
J Am Chem Soc. 2005 Jan 26;127(3):838-9. doi: 10.1021/ja0442769.
7
Synthesis and topoisomerase I inhibitory properties of luotonin A analogues.路脱宁A类似物的合成及其对拓扑异构酶I的抑制特性
Bioorg Med Chem. 2004 Dec 1;12(23):6287-99. doi: 10.1016/j.bmc.2004.08.052.
8
Synthesis and biochemical properties of E-ring modified luotonin A derivatives.E环修饰的路托品A衍生物的合成及生化性质
Bioorg Med Chem Lett. 2004 May 3;14(9):2051-4. doi: 10.1016/j.bmcl.2004.02.069.
9
Water-soluble camptothecin derivatives that are intrinsic topoisomerase I poisons.水溶性喜树碱衍生物,它们是内在的拓扑异构酶I毒物。
Org Lett. 2004 Feb 5;6(3):321-4. doi: 10.1021/ol030119n.
10
Luotonin A. A naturally occurring human DNA topoisomerase I poison.路托西汀A。一种天然存在的人类DNA拓扑异构酶I毒药。
J Am Chem Soc. 2003 Nov 12;125(45):13628-9. doi: 10.1021/ja0368857.